These results are consistent with the studies in a CKD mouse model with intravenous contrast administration, and blockade of TGF-β1/SMAD3 signaling abrogates contrast-mediated expression of fibrotic genes in HK2 cells (a proximal tubular cell line derived from the human kidney) (14). This evidence concerns the gene SMAD3 and chronic kidney disease.